A new trading day began on November 20, 2023, with Heron Therapeutics Inc (NASDAQ: HRTX) stock priced at $1.13, up 19.27% from the previous day of trading. During the day, the shares moved up to $1.39 and dropped to $1.11 before settling in for the closing price of $1.09. HRTX’s price has ranged from $0.50 to $3.41 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 44.61% over the last five years. Meanwhile, its annual earnings per share averaged 44.76%. With a float of $147.77 million, this company’s outstanding shares have now reached $150.07 million.
The firm has a total of 203 workers. Let’s measure their productivity. In terms of profitability, gross margin is +49.04, operating margin of -157.20, and the pretax margin is -169.05.
Heron Therapeutics Inc (HRTX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Heron Therapeutics Inc is 1.53%, while institutional ownership is 78.77%. The most recent insider transaction that took place on Nov 16, was worth 137,970. In this transaction Chief Executive Officer of this company bought 150,000 shares at a rate of $0.92, taking the stock ownership to the 186,496 shares. Before that another transaction happened on Nov 16, when Company’s EVP, Chief Financial Officer bought 85,000 for $0.89, making the entire transaction worth $75,599. This insider now owns 85,000 shares in total.
Heron Therapeutics Inc (HRTX) Earnings and Forecasts
In its latest quarterly report, released on 9/29/2023, the company reported earnings of -$0.17 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of -169.05 while generating a return on equity of -399.43. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 44.76% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 47.50% during the next five years compared to 14.46% growth over the previous five years of trading.
Heron Therapeutics Inc (NASDAQ: HRTX) Trading Performance Indicators
Here are Heron Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.97, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of Heron Therapeutics Inc (HRTX)
Analysing the last 5-days average volume posted by the [Heron Therapeutics Inc, HRTX], we can find that recorded value of 10.11 million was better than the volume posted last year of 2.31 million. As of the previous 9 days, the stock’s Stochastic %D was 93.40%. Additionally, its Average True Range was 0.13.
During the past 100 days, Heron Therapeutics Inc’s (HRTX) raw stochastic average was set at 58.39%, which indicates a significant decrease from 89.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 236.10% in the past 14 days, which was higher than the 120.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8635, while its 200-day Moving Average is $1.5937. Now, the first resistance to watch is $1.4233. This is followed by the second major resistance level at $1.5467. The third major resistance level sits at $1.7033. If the price goes on to break the first support level at $1.1433, it is likely to go to the next support level at $0.9867. Should the price break the second support level, the third support level stands at $0.8633.
Heron Therapeutics Inc (NASDAQ: HRTX) Key Stats
With a market capitalization of 195.09 million, the company has a total of 150,073K Shares Outstanding. Currently, annual sales are 107,670 K while annual income is -182,020 K. The company’s previous quarter sales were 31,760 K while its latest quarter income was -42,060 K.